- Home
- GRFS vs FCFS Comparison
GRFS vs FCFS Comparison
Compare GRFS & FCFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRFS
- FCFS
- Stock Information
- Founded
- GRFS 1940
- FCFS 1988
- Country
- GRFS Spain
- FCFS United States
- Employees
- GRFS N/A
- FCFS N/A
- Industry
- GRFS Biotechnology: Pharmaceutical Preparations
- FCFS Other Specialty Stores
- Sector
- GRFS Health Care
- FCFS Consumer Discretionary
- Exchange
- GRFS Nasdaq
- FCFS Nasdaq
- Market Cap
- GRFS 7.2B
- FCFS 6.5B
- IPO Year
- GRFS 2006
- FCFS 1991
- Fundamental
- Price
- GRFS $10.13
- FCFS $147.13
- Analyst Decision
- GRFS Hold
- FCFS Buy
- Analyst Count
- GRFS 1
- FCFS 3
- Target Price
- GRFS $10.30
- FCFS $137.33
- AVG Volume (30 Days)
- GRFS 794.7K
- FCFS 283.3K
- Earning Date
- GRFS 01-01-0001
- FCFS 10-23-2025
- Dividend Yield
- GRFS 1.41%
- FCFS 1.14%
- EPS Growth
- GRFS 132.60
- FCFS 24.22
- EPS
- GRFS 0.53
- FCFS 6.50
- Revenue
- GRFS $8,744,226,659.00
- FCFS $3,388,177,000.00
- Revenue This Year
- GRFS $6.00
- FCFS $3.73
- Revenue Next Year
- GRFS $6.71
- FCFS $8.14
- P/E Ratio
- GRFS $24.82
- FCFS $22.70
- Revenue Growth
- GRFS 9.32
- FCFS 2.49
- 52 Week Low
- GRFS $6.19
- FCFS $100.24
- 52 Week High
- GRFS $11.14
- FCFS $150.92
- Technical
- Relative Strength Index (RSI)
- GRFS 52.17
- FCFS 61.61
- Support Level
- GRFS $9.57
- FCFS $145.04
- Resistance Level
- GRFS $9.99
- FCFS $150.92
- Average True Range (ATR)
- GRFS 0.18
- FCFS 2.83
- MACD
- GRFS -0.05
- FCFS 0.37
- Stochastic Oscillator
- GRFS 51.85
- FCFS 73.84
About GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
About FCFS FirstCash Holdings Inc.
FirstCash Holdings Inc operates pawn stores in the United States and Latin America. Its primary business involves making small loans secured by personal property. The the company has three reportable segments: U.S. pawn; Latin America pawn; and Retail POS payment solutions (AFF). It derives majority revenue from U.S. Pawn segment. These pawn loans give the borrower the option of either repaying the loans with interest or forfeiting the property without further penalty. Geographically operates in USA, Mexico, Latin America, with maximum revenue from USA.